Skip to content
Screener

Erasca, Inc. ERAS Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.39B-13.4%
Eli Lilly logo
Eli LillyLLY
$10.69B+246%
Pfizer logo
PfizerPFE
$2.62B+12.0%
Amgen logo
AmgenAMGN
$4B+75.5%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-$387.32M-74.7%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$44.36M-6.4%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.34B+1,466%
Enterprise value$6.34B+1,533%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Accounts payable1,1821,794
Accrued expenses and other current and long-term liabilities(3,269)(8,006)
Operating lease assets and liabilities, net(421)(385)
Net cash used in operating activities(27,383)(31,555)
Cash flows from investing activities:
Purchases of marketable securities(253,170)(10,652)
Maturities of marketable securities58,55045,000
Sales of marketable securities100,826

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s operating cash flow?
Erasca, Inc. (ERAS) reported operating cash flow of -$27.38M in Q1 2026.
How has Erasca, Inc.'s operating cash flow changed year-over-year?
Erasca, Inc.'s operating cash flow increased by 13.2% year-over-year, from -$31.56M to -$27.38M.
What is the long-term trend for Erasca, Inc.'s operating cash flow?
Over 4 years (2021 to 2025), Erasca, Inc.'s operating cash flow has grown at a 4.6% compound annual growth rate (CAGR), from -$79.6M to -$95.46M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Erasca, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude